Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model

Frontiers in Psychiatry
Guangfei LiGuolin Ma

Abstract

Schizophrenia is a type of neurodevelopmental psychiatric disorder. However, to date, scientists have not discovered the etiology and effective treatment of this condition. We injected the early growth response gene (EGR3) into the bilateral hippocampus to build a schizophrenia rat model. Behavioral phenotyping and resting-state functional magnetic resonance imaging (rs-fMRI) were used to analyze the behavioral and cerebral alterations in the schizophrenia rat model. The efficacy of risperidone therapy was also evaluated. We divided 34 rats into four groups: schizophrenia model group (E group), sham-operation group (FE group), healthy control group (H group), and risperidone therapy group (T group). Open field test and Morris water maze were conducted as behavioral experiments. Next, we performed rs-fMRI after four weeks of EGR3 transfection and risperidone treatment and analyzed imaging data using regional homogeneity (ReHo), the amplitude of low-frequency fluctuations (ALFF), and functional connectivity (FC). We examined the difference in behavioral and neural activation among the four groups and considered the correlations between behavior and imaging results. EGR3 gene transfection decreased the total moved distance in the ...Continue Reading

References

Oct 12, 2000·The British Journal of Psychiatry : the Journal of Mental Science·F MaedaA Pascual-Leone
May 10, 2001·Biological Psychiatry·H MatsumotoS Frangou
Nov 3, 2001·The American Journal of Psychiatry·A Meyer-LindenbergK F Berman
Apr 28, 2004·NeuroImage·Yufeng ZangLixia Tian
Jun 29, 2004·Clinical Therapeutics·Anthony DeLeonM Lynn Crismon
Apr 6, 2005·Archives of General Psychiatry·Andreas S Meyer-LindenbergKaren Faith Berman
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kazuo YamadaTakeo Yoshikawa
Jan 15, 2008·NeuroImage·Russell A PoldrackThomas E Nichols
Mar 4, 2008·British Journal of Pharmacology·J A PrattB J Morris
Sep 12, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Danielle S BassettAndreas Meyer-Lindenberg
Oct 27, 2009·Schizophrenia Research·Matthew J HoptmanMichael P Milham
Oct 1, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Liang WangTodd S Woodward
Nov 26, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Martijn P van den HeuvelHilleke E Hulshoff Pol
Oct 20, 2011·NeuroImage·Danielle S BassettKelvin O Lim
Sep 18, 2012·Schizophrenia Research·Yuanchao ZhangTianzi Jiang
Jun 7, 2013·JAMA Psychiatry·Martijn P van den HeuvelRené S Kahn
Sep 11, 2014·Neural Regeneration Research·Guolin MaMingxiong Huang
Mar 31, 2015·Biochemical and Biophysical Research Communications·Tianbin SongKefeng Li
Aug 10, 2017·Neuropsychiatric Disease and Treatment·Likun XiaGuihua Jiang
Mar 30, 2018·Frontiers in Behavioral Neuroscience·Yu-Chen ChenJian-Ping Gu

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection

Software Mentioned

spmratIHEP
Statistical Parametric Mapping ( SPM8
SPM

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Related Papers

BMJ : British Medical Journal
J G Edwards
The British Journal of Psychiatry : the Journal of Mental Science
S Bazire
Indian Journal of Psychiatry
P N Kumar
The Medical Letter on Drugs and Therapeutics
© 2021 Meta ULC. All rights reserved